Guidelines : Topical Corticosteroids
Detail
Condition :
Topical Corticosteroids
Keywords :
topical steroids, steroid creams, steroid factsheet, inflammatory skin conditions, steroid potency, eczema, contact dermatitis, Clobetasone butyrate, Alclometasone, Fludroxycortide, Fluocortolone caproate, Fluocortolone pivalate, Fluocinolone acetonide, Betamethasone, Betamethasone valerate, Beclometasone diproprionate, Betamethasone diproprionate, Mometasone furoate, Hydrocortisone butyrate, Fluticasone proprionate, Diflucortolone valerate, hydrocortisone, Clobetasol propionate, Diflucortolone valerate, Enstilar, synalar, betnovate, eumovate, diprosone, diprosalic, dermacort, HC45, lipocream, alphaderm
BNF Codes :
Committee Recommendations
Date
Committee Name
Narrative
Traffic Light Status
03 November 2021
The Topical corticosteroid factsheet has been partially updated to reflect the latest MHRA warnings relating to long-term topical steroid use and the risk of rare, but potentially severe, effects of withdrawal.
The entire document is scheduled for a full review early in 2022
N/A
02 June 2021
Following an MHRA Drug Safety Alert regarding topical corticosteroids, the treatment factsheet was updated and was agreed at the Surrey Heartlands ICS Area Prescribing Committee.
N/A
Documents
Type
Document
Review Date
Safety Information
Supplementary documents (CCG specific documents)
No records returned.